What was Trafalgar International’s price range in the past 12 months?
Trafalgar International lowest stock price was $0.18 and its highest was $3.35 in the past 12 months.
What is Trafalgar International’s market cap?
Trafalgar International’s market cap is $149.37K.
When is Trafalgar International’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Trafalgar International overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Trafalgar International pay dividends?
Trafalgar International does not currently pay dividends.
What is Trafalgar International’s EPS estimate?
Trafalgar International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Trafalgar International have?
Trafalgar International has 199,153 shares outstanding.
Which hedge fund is a major shareholder of Trafalgar International?
Currently, no hedge funds are holding shares in TRFA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Trafalgar International
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.